Dr. Sukeina Nasar (Suki) is a highly skilled pharmacist with expertise in medication therapy management (MTM) and a strong interest in health economics and outcomes research (HEOR). Through her dedication to patient-centered care and a commitment to professional growth, Sukeina is driven to make a meaningful impact in the pharmaceutical industry. She holds a Doctor of Pharmacy degree from Larkin University College of Pharmacy and is licensed as a pharmacist in Florida and Michigan. She carries an additional license as a consultant pharmacist in Florida. Suki engages in ongoing education and remains actively involved in her field, obtaining various certifications in diabetes management, prior authorization, medication therapy management, and managed care pharmacy.
Currently working as a Clinical Pharmacist at Optum, Suki has demonstrated abilities in leading MTM consults with patients, caregivers, nurses, and physicians. Through comprehensive analysis of patient medication profiles, she identifies opportunities for improved adherence, optimized drug utilization, and cost-effective recommendations. Her ability to communicate effectively with Spanish-speaking patients and healthcare providers enables her to engage with diverse populations.
In addition to her professional achievements, Suki is committed to community outreach and involvement. She serves as a member of BasBlue’s Community Committee, a nonprofit organization dedicated to empowering women and non-binary individuals in Detroit through programming, scholarship, and mentorship opportunities. During her tenure as President and Founding Member of the Academy of Managed Care Pharmacy (AMCP) student chapter at Larkin University, she established a platform for students to gain knowledge, experience, and connections in the managed care industry, and she remains an active member of AMCP today.
With her diverse skill set, passion for healthcare, and desire to transition into the HEOR space, Sukeina is poised to contribute significantly to advancing patient care, health outcomes, and the pharmaceutical industry.
Click here for her resume.